{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:59:45Z","timestamp":1767772785305},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087786","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T22:04:21Z","timestamp":1391033061000},"page":"e87786","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Serum CXCL16 as a Novel Marker of Renal Injury in Type 2 Diabetes Mellitus"],"prefix":"10.1371","volume":"9","author":[{"given":"Leping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuofeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1164\/rccm.200501-142OC","article-title":"Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis","volume":"172","author":"C Agostini","year":"2005","journal-title":"American journal of respiratory and critical care medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"AM Aslanian","year":"2006","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","article-title":"Scavenger receptors in atherosclerosis: beyond lipid uptake","volume":"26","author":"KJ Moore","year":"2006","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.atherosclerosis.2007.11.034","article-title":"CXCL16\/SR-PSOX\u2013a friend or a foe in atherosclerosis","volume":"197","author":"Y Sheikine","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions","volume":"24","author":"DM Wuttge","year":"2004","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.4049\/jimmunol.0804112","article-title":"Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion","volume":"182","author":"J Barlic","year":"2009","journal-title":"Journal of immunology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1161\/CIRCULATIONAHA.108.806877","article-title":"Soluble CXCL16 predicts long-term mortality in acute coronary syndromes","volume":"119","author":"AM Jansson","year":"2009","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"F575","DOI":"10.1152\/ajprenal.00063.2007","article-title":"Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury","volume":"293","author":"DM Okamura","year":"2007","journal-title":"American journal of physiology Renal physiology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.2008.181","article-title":"Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney","volume":"74","author":"A Schramme","year":"2008","journal-title":"Kidney international"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2353\/ajpath.2009.080960","article-title":"CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein","volume":"174","author":"P Gutwein","year":"2009","journal-title":"The American journal of pathology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2012.05.014","article-title":"Soluble C-X-C chemokine ligand 16 levels are increased in gout patients","volume":"45","author":"Q Gong","year":"2012","journal-title":"Clinical biochemistry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2362.2011.02473.x","article-title":"Increased plasma CXCL16 levels in patients with chronic kidney diseases","volume":"41","author":"Z Lin","year":"2011","journal-title":"European journal of clinical investigation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0026-0495(73)90243-6","article-title":"Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case","volume":"22","author":"J Berkman","year":"1973","journal-title":"Metabolism: clinical and experimental"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e18398","DOI":"10.1371\/journal.pone.0018398","article-title":"Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese","volume":"6","author":"Z Lin","year":"2011","journal-title":"PloS one"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e15534","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Z Lin","year":"2010","journal-title":"PloS one"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"J Coresh","year":"2007","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"D Fliser","year":"2007","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M311660200","article-title":"CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation","volume":"279","author":"B Chandrasekar","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.172.6.3678","article-title":"A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16","volume":"172","author":"PJ Gough","year":"2004","journal-title":"Journal of immunology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1189\/jlb.1003465","article-title":"Cell surface-anchored SR-PSOX\/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells","volume":"75","author":"T Shimaoka","year":"2004","journal-title":"Journal of leukocyte biology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.171.4.1647","article-title":"Cutting edge: SR-PSOX\/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain","volume":"171","author":"T Shimaoka","year":"2003","journal-title":"Journal of immunology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.4049\/jimmunol.179.10.7166","article-title":"Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis","volume":"179","author":"T Wu","year":"2007","journal-title":"Journal of immunology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejim.2011.12.007","article-title":"Fibrates: therapeutic potential for diabetic nephropathy","volume":"23","author":"I Kouroumichakis","year":"2012","journal-title":"European journal of internal medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2215\/CJN.00920112","article-title":"Obstetric nephrology: pregnancy in women with diabetic nephropathy\u2013the role of antihypertensive treatment","volume":"7","author":"ER Mathiesen","year":"2012","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1681\/ASN.2007030276","article-title":"Activation of adenosine 2A receptors preserves structure and function of podocytes","volume":"19","author":"AS Awad","year":"2008","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1111\/j.1582-4934.2009.00761.x","article-title":"CXCL16 and oxLDL are induced in the onset of diabetic nephropathy","volume":"13","author":"P Gutwein","year":"2009","journal-title":"Journal of cellular and molecular medicine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:10:06Z","timestamp":1589015406000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087786"}},"subtitle":[],"editor":[{"given":"Utpal","family":"Sen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087786","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]}}}